Tesamorelin/ CJC-1295/ Ipamorelin 12mg Blend

Tesamorelin / CJC-1295 / Ipamorelin 12mg Blend — Research Grade

This research blend combines Tesamorelin, CJC-1295, and Ipamorelin into a single 12mg formulation. Tesamorelin is a stabilized GHRH analogue studied for visceral fat reduction and GH/IGF-1 stimulation. CJC-1295 provides sustained pulsatile GH release, and Ipamorelin selectively amplifies GH secretion without cortisol elevation. Together, this triple-peptide stack is studied for its broad and synergistic effects on the GH axis, metabolic regulation, and body composition. This product is supplied in lyophilized (powder) form and is intended strictly for in vitro and laboratory research purposes.

Key Research Areas

• Triple-pathway GH axis activation (GHRH + GHRP synergy)
• Visceral adipose tissue reduction and lipid metabolism (Tesamorelin)
• Pulsatile GH secretion and IGF-1 regulation (CJC-1295)
• Selective GH amplification without cortisol elevation (Ipamorelin)
• Body composition, metabolic optimization, and recovery research

Product Details

• Total Concentration: 12mg blend (Tesamorelin / CJC-1295 / Ipamorelin)
• Purity: Research grade
• Format: Lyophilized powder
• Storage: Store at -20°C; protect from light and moisture
• Reconstitution: Recommended with bacteriostatic water

For research use only. Not intended for human or veterinary use. This product has not been evaluated by the FDA and is not approved for therapeutic or diagnostic use.